Company Encyclopedia
View More
name
Sharps Tech
STSS.US
Sharps Technology, Inc., a medical device and pharmaceutical packaging company, engages in the design, research and development, manufacturing, and commercialization of safety syringe products in the United States. The company provides safety syringe products comprising Securgard, Sologard, and Sharps Provensa that are ultra-low waste syringes for passive, and safety and reuse prevention features, as well as develops prefillable syringe systems. The company was incorporated in 2017 and is based in Melville, New York.
373.19 B
STSS.USMarket value -Rank by Market Cap -/-

Financial Score

26/12/2025 Update
D
Health Care SuppliesIndustry
Industry Ranking39/43
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreE
    • ROE-47.47%E
    • Profit Margin-34070.06%E
    • Gross Margin-1398.74%E
  • Growth ScoreC
    • Revenue YoY0.00%C
    • Net Profit YoY-1225.96%E
    • Total Assets YoY3844.94%A
    • Net Assets YoY6558.99%A
  • Cash ScoreC
    • Cash Flow Margin-0.29%D
    • OCF YoY0.00%C
  • Operating ScoreE
    • Turnover0E
  • Debt ScoreA
    • Gearing Ratio2.42%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Short Interest in Sharps Technology, Inc. (NASDAQ:STSS) Rises By 265.1%

    Sharps Technology, Inc. (NASDAQ:STSS) experienced a significant increase in short interest in December, rising by 265.1% to 614,624 shares as of December 15th. Approximately 2.2% of the company's shares are short sold. The short-interest ratio is 2.4 days based on an average daily volume of 258,717 shares. Several analysts have rated the stock as 'sell'.

    Market Beat·
    US
    STSS
    +0.91%
    Market Beat·
    US
    STSS
    +0.91%

    Sharps Technology Director Annemarie Tierney Resigns Amid Conflict Concerns

    Sharps Technology Inc. announced the resignation of Annemarie Tierney as Independent Director and member of the Audit and Compensation Committees, effective December 19, 2025. Paul Danner, Alice Zhang, and Andrew Crescenzo will serve on the Treasury Oversight Committee. The original content was published via EDGAR by Sharps Technology Inc. on December 23, 2025.

    Reuters·
    US
    STSS
    +0.91%
    Reuters·
    US
    STSS
    +0.91%

    Sharps Technology shares are trading lower. The company reported Q3 financial results.

    benzinga_article·
    US
    STSS
    +0.91%
    benzinga_article·
    US
    STSS
    +0.91%

    Can Sharps Technology’s Solana treasury prove ‘strongest balance sheet’ claims?

    Sharps Technology announced major changes in Q3 2025, raising $411 million through a PIPE deal and shifting focus from syringe manufacturing to medical device distribution and Solana-based digital asset management. The company holds over 2 million SOL, generating $17.7 million in staking revenue. Despite these moves, Sharps' stock fell 7.14% to $2.86. The company aims to boost margins and finances through its blockchain strategy, though market skepticism remains. Solana's price also declined, yet institutional confidence in the asset persists.

    Amb Crypto·
    US
    STSS
    +0.91%
    Amb Crypto·
    US
    STSS
    +0.91%

    Sharps Technology Reports Strong Q3 Growth and Completes Exit from Syringe Manufacturing

    Sharps Technology Inc. reported strong Q3 growth, raising $411 million through PIPE financing. The company holds over 2.0 million SOL and generated $17.7 million in staking revenue and digital-asset gains. Liquidity stood at $25.2 million. They exited syringe manufacturing, focusing on higher-margin medical devices and maximizing value from their Solana-based digital assets.

    Reuters·
    US
    STSS
    +0.91%
    Reuters·
    US
    STSS
    +0.91%
    © 2025 Longbridge｜Disclaimer